ReviewAtrial fibrillation: Profile and burden of an evolving epidemic in the 21st century
Introduction
Atrial fibrillation (AF), the most common sustained cardiac arrhythmia and one of the most common cardiovascular conditions overall, is a “spectrum disorder” that spans isolated and benign episodes of electrical disturbance to a chronic condition that results in cardiac remodelling and functional impairment. AF is undoubtedly a progressive disorder with paroxysmal episodes becoming more frequent and persistent and persistent episodes often becoming permanent. Classification of AF sub-types reflects this natural history comprising “first diagnosed” AF, self-terminating paroxysmal episodes (transient to persistent) and the long-standing and permanent form of AF that defies attempts to achieve sinus rhythm [1]. However, much of the literature describing its epidemiology does not differentiate between paroxysmal versus persistent forms of AF: the minimum common standard for its detection being an episode of AF captured on ECG.
Advances have been made over recent decades to — a) improve our understanding of the evolving burden of AF, b) increase surveillance for its presence, c) accurately diagnose and characterise the sub-type of AF presentation (i.e. “first diagnosed”, paroxysmal, persistent or permanent) and d) improve its therapeutic management through the combination of pharmacological [2], [3], interventional [4], [5] and surgical [6], strategies. However, AF continues to have a significant impact on quality of life [7], morbidity and mortality [8]. In high income countries, the number of affected individuals is projected to increase exponentially over the next four decades [9]. Parallel increases in low-to-middle income countries due to epidemiological transition and an overall rise in non-communicable forms of heart disease are also likely [10]. Overall, therefore, AF exerts a major but evolving public health, social and economic burden worldwide. Notwithstanding the caveats and limitations to providing a succinct review of a large and heterogeneous literature base, the overall aim of this report is to provide an accurate, valid and comprehensive description of the evolving burden of AF by collating and synthesising data from the largest and most robust scientific reports.
Section snippets
Search strategy
Initially, all relevant publications and research reports on the epidemiology and global burden of AF were identified using specific search terms (refer to Appendix 1) via PubMed (incorporating literature that would be identified from many other bibliographic databases such as MEDLINE [11]). Searches were limited to English-language material published up to May, 2012. No restriction on earliest publication date was imposed. Therefore, manuscripts from as early as 1985 were included.
Antecedents
There are numerous reports of modifiable and non-modifiable risk factors that contribute to the development of AF. Table 1 provides a summary of the most commonly reported contributors to AF. These include socio-demographic factors, adverse lifestyle choices, cardiovascular conditions and other co-morbid conditions [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33]. The population prevalence of each of the common
Discussion
With a clear understanding of the caveats around trying to categorise and describe a nebulous body of studies and reports focussing on AF, this report provides a contemporary picture of the evolving impact of AF, predominantly from a high-income country perspective. As expected, all relevant data indicate that the current clinical and financial burden of AF is profound and shows no signs of slowing in the foreseeable future. Paradoxically, this phenomenon largely reflects improved longevity
Author declaration
The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in the International Journal of Cardiology.
Acknowledgements
The SAFETY study is funded by a National Health and Medical Research Council of Australia Program Grant (519823). In addition, JB, MC and SS are supported by the National Health and Medical Research Council of Australia. This study is supported in part by the Victorian Government's Operational Infrastructure Support Program.
References (155)
- et al.
Trends in case-fatality in 22968 patients admitted for the first time with atrial fibrillation in Scotland, 1986–1995
Int J Cardiol
(2002) - et al.
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates
Am J Cardiol
(1998) - et al.
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study
Am J Med
(2002) - et al.
Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation
Am J Hum Genet
(2004) - et al.
A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation
Biochem Biophys Res Commun
(2005) Genetic determinants of atrial fibrillation: SNPs are riding the wave(lets)
Heart Rhythm
(2006)- et al.
Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation?
J Am Coll Cardiol
(2007) - et al.
Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death
Cell
(2008) - et al.
Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome
J Am Coll Cardiol
(2002) - et al.
Prevalence of early-onset atrial fibrillation in congenital long QT syndrome
Heart Rhythm
(2008)
A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation
Heart Rhythm
Secular trends in the prevalence of atrial fibrillation: the Framingham Study
Am Heart J
The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study
Am J Med
The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades
J Am Coll Cardiol
Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese
Int J Cardiol
Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study
Am Heart J
Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004
Ann Emerg Med
Epidemiology and determinants of outcome of admissions for atrial fibrillation in the United States from 1996 to 2001
Am J Cardiol
Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study
J Am Coll Cardiol
Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care
J Am Coll Cardiol
Trends in stroke incidence after hospitalization for atrial fibrillation in Sweden 1987 to 2006
Int J Cardiol
Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies
J Am Coll Cardiol
Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation
Mayo Clin Proc
Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation
J Am Coll Cardiol
Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective
Am Heart J
New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience
Am Heart J
Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective
Am Heart J
Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries
J Am Coll Cardiol
Cost of care distribution in atrial fibrillation patients: the COCAF study
Am Heart J
Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States
Value Health
The costs of care in atrial fibrillation and the effect of treatment modalities in Germany
Value Health
Carotid endarterectomy in the U.K. and Ireland: audit of 30-day outcome. The Audit Committee for the Vascular Surgical Society
Eur J Vasc Endovasc Surg
Rates and implications for hospitalization of patients >/= 65 years of age with atrial fibrillation/flutter
Am J Cardiol
Prevalence of atrial fibrillation in US Nursing Homes: results from the National Nursing Home Survey, 1985–2004
J Am Med Dir Assoc
Increasing prevalence of atrial fibrillation and flutter in the United States
Am J Cardiol
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
Eur Heart J
A comparison of rate control and rhythm control in patients with atrial fibrillation
N Engl J Med
Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin
Circulation
Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation
Eur Heart J
A new solution for an old problem? Effects of a nurse-led, multidisciplinary, home-based intervention on readmission and mortality in patients with chronic atrial fibrillation
J Cardiovasc Nurs
Surgery for atrial fibrillation
Nat Rev Cardiol
Quality of life in patients with atrial fibrillation: a systematic review
Am J Med
Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
JAMA
Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the Heart of Soweto Study
Heart
Trends in out-of-hospital deaths due to coronary heart disease in Sweden (1991 to 2006)
Circulation
Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men
Eur Heart J
Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study
JAMA
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring
JAMA
Identification of a genetic locus for familial atrial fibrillation
N Engl J Med
Cited by (504)
Predicting Adverse Outcomes Following Catheter Ablation Treatment for Atrial Flutter/Fibrillation
2024, Heart Lung and CirculationRelationship of health-related social needs and hospital readmissions in patients following a hospitalization for atrial fibrillation
2023, American Heart Journal Plus: Cardiology Research and PracticeEmergency medicine updates: Atrial fibrillation with rapid ventricular response
2023, American Journal of Emergency MedicineDAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis
2023, JACC: Cardiovascular InterventionsOral Anticoagulant Therapy and Risk of Admission to Long-Term Care in patients With Atrial Fibrillation: A Nationwide Cohort Study
2023, Journal of the American Medical Directors Association